Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SEVELAMER CARBONATE, with a corresponding US DMF Number 27926.
Remarkably, this DMF maintains an Active status since its submission on February 07, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 13, 2014, and payment made on February 07, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II